- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 267/18 - [b, e]-condensed
Patent holdings for IPC class C07D 267/18
Total number of patents in this class: 14
10-year publication summary
|
3
|
0
|
0
|
0
|
2
|
0
|
2
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Icahn School of Medicine at Mount Sinai | 1032 |
2 |
| Pontificia Universidad Catolica de Chile | 316 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3003 |
2 |
| University of Maryland, Baltimore | 1067 |
2 |
| Amgen Inc. | 4429 |
1 |
| IntelGenx Corp. | 64 |
1 |
| MethylGene Inc. | 32 |
1 |
| The USA, as represented by the Secretary, Dept. of Health and Human Services | 87 |
1 |
| Neumora Therapeutics, Inc. | 84 |
1 |
| Zevra Therapeutics, Inc. | 99 |
1 |
| Other owners | 0 |